VG Life Sciences Inc. - FORM 10-K - EX-21.1 - SUBSIDIARIES OF REGISTRANT - April 15, 2015

Attached files

file filename
EX-4.2 - WARRANT TO PURCHASE STOCK - VG Life Sciences Inc.vgls_ex402.htm
EX-4.3 - WARRANT TO PURCHASE STOCK - VG Life Sciences Inc.vgls_ex403.htm
EX-4.6 - WARRANT TO PURCHASE STOCK - VG Life Sciences Inc.vgls_ex406.htm
EX-4.8 - WARRANT TO PURCHASE STOCK - VG Life Sciences Inc.vgls_ex408.htm
EX-4.4 - WARRANT TO PURCHASE STOCK - VG Life Sciences Inc.vgls_ex404.htm
EX-4.5 - WARRANT TO PURCHASE STOCK - VG Life Sciences Inc.vgls_ex405.htm
EX-4.7 - WARRANT TO PURCHASE STOCK - VG Life Sciences Inc.vgls_ex407.htm
EX-14.1 - CODE OF ETHICS - VG Life Sciences Inc.vgls_ex1401.htm
EXCEL - IDEA: XBRL DOCUMENT - VG Life Sciences Inc.Financial_Report.xls
EX-31.1 - CERTIFICATION - VG Life Sciences Inc.vgls_ex3101.htm
EX-32.1 - CERTIFICATION - VG Life Sciences Inc.vgls_ex3201.htm
EX-31.2 - CERTIFICATION - VG Life Sciences Inc.vgls_ex3102.htm
10-K - ANNUAL REPORT - VG Life Sciences Inc.vgls_10k-123114.htm
EX-23.1 - CONSENT - VG Life Sciences Inc.vgls_ex2301.htm
EX-10.160 - SUBSCRIPTION AGREEMENT - VG Life Sciences Inc.vgls_ex10160.htm
EX-10.158 - CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT - VG Life Sciences Inc.vgls_ex10158.htm
EX-10.172 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc.vgls_ex10170.htm
EX-10.172 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vgls_ex10172.htm
EX-10.169 - CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT - VG Life Sciences Inc.vgls_ex10169.htm
EX-10.171 - CONVERTIBLE DEBENTURE AND WARRANT PURCHASE AGREEMENT - VG Life Sciences Inc.vgls_ex10171.htm
EX-10.173 - UNSECURED REVOLVING CREDIT NOTE - VG Life Sciences Inc.vgls_ex10173.htm
EX-10.163 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vgls_ex10163.htm
EX-10.168 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vgls_ex10168.htm
EX-10.164 - CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT - VG Life Sciences Inc.vgls_ex10164.htm
EX-10.167 - CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT - VG Life Sciences Inc.vgls_ex10167.htm
EX-10.166 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc.vgls_ex10166.htm
EX-10.162 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vgls_ex10162.htm
EX-10.157 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc.vgls_ex10157.htm
EX-10.159 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc.vgls_ex10159.htm
EX-10.165 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc.vgls_ex10165.htm
EX-10.156 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc.vgls_ex10156.htm
EX-10.161 - SERVICES AGREEMENT - VG Life Sciences Inc.vgls_ex10161.htm

Exhibit 21.1

 

Subsidiaries of Registrant

 

 

Subsidiary Name

  

Ownership

Percentage

V-Clip Pharmaceuticals, Inc., a California corporation   100%
Carcinotek, Inc., a California corporation   100%
White Label Generics, Inc., a California corporation   49%
MetaCytolytics, Inc., a Delaware corporation   100%
VG Energy, Inc., a Delaware corporation   81.65%

 

VG Life Sciences Inc. Reports